Supraorbital Nerve and Cavernous Sinus Invasion with Poorly Differentiated Carcinoma of Unknown Primary

被引:1
|
作者
Patel, Saagar N. [1 ]
Nakawah, Mohammad Obadah [2 ]
Sadaka, Ama [3 ]
Berry, Shauna [3 ]
Gomez, Juan Ortiz [3 ,4 ]
Powell, Suzanne [3 ]
Lee, Andrew G. [3 ,5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Baylor Coll Med, Sch Med, Houston, TX 77030 USA
[2] Houston Methodist Hosp, Dept Neurol, Houston, TX USA
[3] Houston Methodist Hosp, Blanton Eye Inst, Dept Ophthalmol, Houston, TX USA
[4] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA
[5] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA
[6] Weill Cornell Med, Dept Ophthalmol, New York, NY USA
[7] Weill Cornell Med, Dept Neurol, New York, NY USA
[8] Weill Cornell Med, Dept Neurosurg, New York, NY USA
[9] Univ Texas MD Anderson Canc Ctr, Sect Ophthalmol, Houston, TX 77030 USA
[10] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA 52242 USA
关键词
Carcinoma; perineural invasion; cavernous sinus; supraorbital nerve;
D O I
10.1080/01658107.2017.1401093
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A 50-year-old man presented with a 4-month history of right-sided trigeminal neuropathy in the V1 and V2 distribution, right sixth nerve palsy and Homer syndrome. Magnetic resonance imaging (MRI) showed enhancement and thickening along the right ophthalmic nerve and supraorbital nerve and fullness at the right cavernous sinus extending to Meckel's cave. Evaluation for a primary tumour was negative. Cavernous sinus biopsy showed infiltrating poorly differentiated carcinoma; the patient underwent radiation therapy. To our knowledge this is the only case of poorly differentiated carcinoma involving the supraorbital nerve presenting with trigeminal neuropathy and Homer syndrome in the English ophthalmic literature.
引用
收藏
页码:312 / 315
页数:4
相关论文
共 50 条
  • [1] POORLY DIFFERENTIATED CARCINOMA AND POORLY DIFFERENTIATED ADENOCARCINOMA OF UNKNOWN PRIMARY TUMOR SITE
    HAINSWORTH, JD
    GRECO, FA
    SEMINARS IN ONCOLOGY, 1993, 20 (03) : 279 - 286
  • [2] Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: Favorable subsets of patients with unknown-primary carcinoma?
    Lenzi, R
    Hess, KR
    Abbruzzese, MC
    Raber, MN
    Ordonez, NG
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2056 - 2066
  • [3] POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF UNKNOWN PRIMARY TUMOR SITE
    GARROW, GC
    GRECO, FA
    HAINSWORTH, JD
    SEMINARS IN ONCOLOGY, 1993, 20 (03) : 287 - 291
  • [4] THE ROLE OF ETOPOSIDE IN THE TREATMENT OF POORLY DIFFERENTIATED CARCINOMA OF UNKNOWN PRIMARY SITE
    HAINSWORTH, JD
    JOHNSON, DH
    GRECO, FA
    CANCER, 1991, 67 (01) : 310 - 314
  • [5] THE MANAGEMENT OF PATIENTS WITH ADENOCARCINOMA AND POORLY DIFFERENTIATED CARCINOMA OF UNKNOWN PRIMARY SITE
    GRECO, FA
    HAINSWORTH, JD
    SEMINARS IN ONCOLOGY, 1989, 16 (04) : 116 - 122
  • [6] Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site
    Hainsworth, JD
    Lennington, WJ
    Greco, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 632 - 635
  • [7] Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report
    Zerdan, Maroun Bou
    Hamouche, Ramzi
    Bouferraa, Youssef
    Chouairy, Camil
    Gholam, Dany
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [8] POORLY DIFFERENTIATED CARCINOMA OF UNKNOWN PRIMARY SITE - CLINICAL USEFULNESS OF IMMUNOPEROXIDASE STAINING
    HAINSWORTH, JD
    WRIGHT, EP
    JOHNSON, DH
    DAVIS, BW
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) : 1931 - 1938
  • [9] ADVANCED POORLY DIFFERENTIATED CARCINOMA OF UNKNOWN PRIMARY SITE - RECOGNITION OF A TREATABLE SYNDROME
    GRECO, FA
    VAUGHN, WK
    HAINSWORTH, JD
    ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) : 547 - 553
  • [10] Clinical characteristics of cancer of unknown primary cancer with poorly differentiated carcinoma and adenocarcinoma
    Kodaira, Makoto
    Shimoi, Tatsunori
    Hashimoto, Jun
    Yamamoto, Harukaze
    Yunokawa, Mayu
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2015, 26 : 86 - 86